Yalcin, A. D. Et Al. 2014. Anti-IgE Monoclonal Antibody (Omalizumab) is effective in Treating Bullous Pemphigoid and Its Effects on Soluble CD200. CLINICAL LABORATORY , vol.60, no.3 , 523-524.

Yalcin, A. D., Genc, G. E., Celik, B., & GÜMÜŞLÜ, S., (2014). Anti-IgE Monoclonal Antibody (Omalizumab) is effective in Treating Bullous Pemphigoid and Its Effects on Soluble CD200. CLINICAL LABORATORY , vol.60, no.3, 523-524.

Yalcin, Arzu Et Al. "Anti-IgE Monoclonal Antibody (Omalizumab) is effective in Treating Bullous Pemphigoid and Its Effects on Soluble CD200," CLINICAL LABORATORY , vol.60, no.3, 523-524, 2014

Yalcin, Arzu D. Et Al. "Anti-IgE Monoclonal Antibody (Omalizumab) is effective in Treating Bullous Pemphigoid and Its Effects on Soluble CD200." CLINICAL LABORATORY , vol.60, no.3, pp.523-524, 2014

Yalcin, A. D. Et Al. (2014) . "Anti-IgE Monoclonal Antibody (Omalizumab) is effective in Treating Bullous Pemphigoid and Its Effects on Soluble CD200." CLINICAL LABORATORY , vol.60, no.3, pp.523-524.

@article{article, author={Arzu Didem Yalcin Et Al. }, title={Anti-IgE Monoclonal Antibody (Omalizumab) is effective in Treating Bullous Pemphigoid and Its Effects on Soluble CD200}, journal={CLINICAL LABORATORY}, year=2014, pages={523-524} }